Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|18|27|4244-4257
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.18, Iss.27, 2012-09, pp. : 4244-4257
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
Current Drug Targets, Vol. 11, Iss. 8, 2010-01 ,pp. :
Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy
Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. :
Anti-Angiogenic Therapies for Children with Cancer
Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. :
Antibody-based antiangiogenic cancer therapy
By Sanz Laura Álvarez-Vallina Luis
Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. :